RxDoctor Payments Data

Rod Passman, MD

Clinical Cardiac Electrophysiology · Chicago, ILNPI 1982639688

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (36.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medtronic at 46.5% of the total.

$92,412in general payments, 2019–2025

Across 267 payments — averaging $346.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$43K
  • Boston Scientific$22K
  • Irhythm Technologies, Inc.$10K
  • Abbott$7K
  • Medical Device Business Services, Inc.$5K
  • Sanofi-aventis U.S. LLC$3K
  • plus $3K from 17 others
$80,562in research payments, 2019–2025

Across 31 payments — averaging $2598.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$23K
  • Abbott$23K
  • Janssen Scientific Affairs, LLC$19K
  • Boston Scientific$17K

What the payments were for

  • Consulting fees$33,84737%
  • Speaking & faculty fees$34,00237%
  • Travel & lodging$12,66714%
  • Food & beverage$11,89613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,412 in reported general payments places this provider in the 85th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$220,983
Medicare patients
578
Services billed
2,564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban293$392,481
MultaqDronedarone Hcl88$135,646
XareltoRivaroxaban97$126,315
Dofetilide36$12,336
Flecainide Acetate223$9,763
Propafenone Hcl ErPropafenone Hcl20$6,057
Amiodarone Hcl296$5,305
Metoprolol Succinate137$3,288
Diltiazem 24hr Er (Cd)Diltiazem Hcl44$925
Warfarin Sodium25$339
SotalolSotalol Hcl20$293
Metoprolol Tartrate18$191
Sotalol AfSotalol Hcl12$80

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sanofi-aventis U.S. LLCMultaq$2,556$135,64688 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

Other clinical cardiac electrophysiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →